Neonatal Spinal Anesthesia: Effects of the Addition of Clonidine

Verified by: University Hospital, Montpellier, June 2009
First Received: May 12, 2009 | Last Updated: February 24, 2010 | Phase: Phase 4 | Start Date: November 2006
Overall Status: Recruiting | Estimated Enrollment: 120
  • …
  • Tell a FriendPrint

This prospective, double blinded study investigates spinal anesthesia with or without clonidine added to bupivacaine in newborns. This study is based on duration measurement of spinal anesthesia and cardio respiratory recording during 24h for apnea detection...

Brief Summary

Official Title: “Neonatal Spinal Anesthesia: Effects of the Addition of Clonidine”

This prospective, double blinded study investigates spinal anesthesia with or without clonidine added to bupivacaine in newborns. This study is based on duration measurement of spinal anesthesia and cardio respiratory recording during 24h for apnea detection.

  • Study Type: Interventional
  • Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
  • Study Primary Completion Date: November 2006

Detailed Clinical Trial Description

Ex premies and term neonates are two subgroups investigated separately. The overall objective is to validate lengthening of spinal anesthesia in newborns in order to avoid "rescue" general anesthesia that occur in 20-40 % of patients with plain bupivacaine.

Intervention(s) in this Clinical Trial

  • Drug: clonidine
    • addition of 1 µg/kg of clonidine to bupivacaine 1 mg/kg as spinal anesthesia
  • Drug: clonidine
    • equivalent volume of saline added to bupivacaine, 1 mg/kg as spinal anesthesia

Arms, Groups and Cohorts in this Clinical Trial

  • Placebo Comparator: prematurely born, bupivacaine, placebo
  • Experimental: prematurely born, bupivacaine, clonidine
  • Placebo Comparator: term neonate, bupivacaine, placebo
  • Experimental: term neonate, bupivacaine, clonidine

Outcome Measures for this Clinical Trial

Primary Measures

  • number of "rescue" general anesthesia
    • Time Frame: end of surgery
      Safety Issue?: No

Secondary Measures

  • apnea and desaturation occurrence
    • Time Frame: during 24h
      Safety Issue?: Yes
  • duration of spinal anesthesia
    • Time Frame: during 24h
      Safety Issue?: Yes

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • Newborns less than 60 weeks old post-conceptional, former premature or not
  • Newborns requiring inguinal hernia or lower limbs surgery,
  • infants needing no more critical care assistance
  • Informed consent of parents

Exclusion Criteria:

  • Spinal malformation,
  • Coagulopathy,
  • critical hemodynamics,
  • uncontrolled neurologic or metabolic pathology.
  • infection at injection point.

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: N/A

Maximum Age for this Clinical Trial: 60 Weeks

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Investigator Information

Lead Investigator: University Hospital, Montpellier Other

Overall Clinical Trial Officials and Contacts

Xavier Capdevila, PhD Study Chair CHU de Montpellier, France  

Overall Contact: Alain Rochette, MD (33)467338256 a-rochette@chu-montpellier.fr

Related Publications

References

Rochette A, Raux O, Troncin R, Dadure C, Verdier R, Capdevila X. Clonidine prolongs spinal anesthesia in newborns: a prospective dose-ranging study. Anesth Analg. 2004 Jan;98(1):56-9, table of contents.

Rochette A, Troncin R, Raux O, Dadure C, Lubrano JF, Barbotte E, Capdevila X. Clonidine added to bupivacaine in neonatal spinal anesthesia: a prospective comparison in 124 preterm and term infants. Paediatr Anaesth. 2005 Dec;15(12):1072-7.

Additional Information

Information obtained from ClinicalTrials.gov on February 08, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT01075490

Study ID Number: UF7874

ClinicalTrials.gov Identifier: NCT01075490

Health Authority: France: Institutional Ethical Committee

  • …
  • Tell a FriendPrint

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT01075490